Further experiments suggested that SETD1A promoted Wnt/β-catenin pathway activity and the malignant behaviors in NSCLC cells, at least, partly by upregulating NEAT1 and EZH2 expression. Here, NEAT1 is linked to non-small cell lung carcinoma.